Clinical reference
Endocrine · Somatostatin analog · Neonatology, Pediatrics, Endocrinology
Somatostatin analog for refractory hyperinsulinemic hypoglycemia and chylothorax (adjunct). Hyperinsulinemic hypoglycemia: 1 mcg/kg/dose subQ or IV every 6 h, titrate to effect (max 10 mcg/kg/dose q6h). Chylothorax: 1 mcg/kg/h IV continuous, titrate (max 10 mcg/kg/h); wean over 2–7 days. Monitor blood glucose; monitor for NEC.